Examples of using Edss in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Progression on EDSS.
EDSS: Expanded Disability Status Scale Gd+: Gadolinium-enhancing.
Progression without relapse for 1 EDSS during 6 months.
EDSS≤ 6 in the absence of pregnancy and the approval of the hospital committee for drugs.
Progression accompanied relapses for 1 EDSS during 12 months.
EDSS(Expanded disability Status scale)- Kurtzkeova scale levels of neurological damage after functional systems FS.
Increasing flomax buy indicates lessning anddisgusted strangly on counterfeit terbinafine in its tratamiento range edss 4.
First public EDSS calculator(http://edss.neurol.ru) is developed, which allows to standardisation of neurostatus scoring.
Fampyra is indicated for the improvement of walking in adultpatients with multiple sclerosis with walking disability EDSS 4-7.
Patients in the dronabinol group had EDSS(expanded disability status scale) score progression compared with 73 in the placebo group.
Participation is open to patients with high disease activity,as well as patients without relapses and without an increase in EDSS in the last two years.
Patients had an EDSS from 0-3.0, at least 2 clinical episodes of MS in the prior 2 years, and≥1 gadolinium-enhancing lesion at study entry.
Time to onset of SRD was defined as a decrease of at least one point on the EDSS from a baseline EDSS score≥ 2 that was sustained for at least 6 months.
After 3 years, a pre-planned interim analysis showed EDSS progression(confirmed increase in EDSS of greater than or equal to 1.0 compared to baseline) occurred in 24% of the patients in the delayed treatment group compared to 16% in the immediate treatment group Hazard Ratio 0.6, 95% confidence interval(0.39, 0.92), p=0.022.
The primary outcome measures were time to diagnosis of CDMS(Clinically Definite MS),time to confirmed EDSS(Expanded Disability Status Scale) progression and patient reported Quality of Life outcomes FAMS-TOI.
Efficacy as monotherapy has been evaluated in one randomised, double-blind, placebo-controlled study lasting 2 years(AFFIRM study) in relapsing-remitting MS patients who had experienced at least 1 clinical relapse during the year prior to entry andhad a Kurtzke Expanded Disability Status Scale(EDSS) score between 0 and 5.
The Expanded Disability Status Scale(EDSS) is a scale system for a systematic acquisition of the disability of neurological patients suffering from multiple sclerosis.
In the treatment of MS and who still use the existing three criteria diksriminirajuća in MS, However, the prescribing of 1. linije imply the absence of neurologic, but does not exceed the EDSS 4. to 2. line treatment EDSS should not exceed the value 6 and there should be minimal disability cane or crutches in one hand.
In a 3-year study in patients with secondary progressive multiple sclerosis(EDSS 3-6.5) with evidence of clinical progression in the preceding two years and who had not experienced relapses in the preceding 8 weeks, Rebif had no significant effect on progression of disability, but relapse rate was reduced by approximately 30.
Factors associated with a higher risk of relapsepostpartatalnog are higher relapse rate and EDSS greater before pregnancy and previously not using immunomodulatory therapy and relapse during pregnancy.
Progression of disability was defined as at least a 1.0 point increase on the EDSS from a baseline EDSS> =1.0 sustained for 12 or 24 weeks or at least a 1.5 point increase on the EDSS from a baseline EDSS =0 sustained for 12 or 24 weeks.
Time to onset of SAD was defined as an increase of at least 1 point on the expanded disability status scale(EDSS) from a baseline EDSS score≥ 1.0(1.5 point increase for patients with baseline EDSS of 0) that was sustained for 6 months.